Fiera Capital (Canada)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-30,235
Closed -$2.27M 599
2022
Q2
$2.27M Sell
30,235
-554
-2% -$24.6K 0.01% 291
2022
Q1
$827K Sell
30,789
-1,072
-3% -$36K ﹤0.01% 460
2021
Q4
$1.52M Sell
31,861
-2,811
-8% -$126K ﹤0.01% 364
2021
Q3
$2.3M Sell
34,672
-419
-1% -$29.8K 0.01% 282
2021
Q2
$2.74M Sell
35,091
-2,479
-7% -$183K 0.01% 257
2021
Q1
$3.55M Buy
37,570
+1,299
+4% +$154K 0.01% 225
2020
Q4
$4.42M Sell
36,271
-497
-1% -$54.5K 0.01% 258
2020
Q3
$3.21M Sell
36,768
-1,036
-3% -$72.2K 0.01% 267
2020
Q2
$2.44M Sell
37,804
-1,342
-3% -$77.4K 0.01% 298
2020
Q1
$1.75M Sell
39,146
-1,360
-3% -$72.2K 0.01% 334
2019
Q4
$2.52M Buy
+40,506
New +$1.93M 0.01% 331

Fiera Capital (Canada)'s TPTX Position: Q3 2022 in Review

Fiera Capital (Canada) sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 30,235 shares — an estimated $2.27M sold.

Fiera Capital (Canada) first reported a position in TPTX in Q4 2019 and held it in 11 quarters. The position peaked at $4.42M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Fiera Capital (Canada) reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Fiera Capital (Canada) sold 30,235 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.27M.
  • Fiera Capital (Canada) first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
  • Fiera Capital (Canada)'s Turning Point Therapeutics, Inc. Common Stock position peaked at $4.42M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2022, filed 3 Nov 2022.